blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3997704

EP3997704 - IMPROVING DIAGNOSIS FOR VARIOUS DISEASES USING TUMOR MICROENVIRONMENT ACTIVE PROTEINS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  15.04.2022
Database last updated on 17.05.2024
FormerThe international publication has been made
Status updated on  22.01.2021
Most recent event   Tooltip16.01.2024The date on which the examining division becomes responsible, has been established 
16.01.2024Amendment by applicant 
Applicant(s)For all designated states
Otraces Inc.
9119 Gaither Road
Rockville, Maryland 20877 / US
[2022/19]
Inventor(s)01 / KRASIK, Galina
9700 Great Seneca Highway
Rockville, Maryland 20850 / US
02 / LINGENFELTER, Keith
9700 Great Seneca Highway
Rockville, MD 20850 / US
 [2022/19]
Representative(s)Gill Jennings & Every LLP
The Broadgate Tower
20 Primrose Street
London EC2A 2ES / GB
[2022/19]
Application number, filing date20840591.013.07.2020
[2022/20]
WO2020US41838
Priority number, dateUS201962873862P13.07.2019         Original published format: US 201962873862 P
[2022/19]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021011491
Date:21.01.2021
Language:EN
[2021/03]
Type: A1 Application with search report 
No.:EP3997704
Date:18.05.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 21.01.2021 takes the place of the publication of the European patent application.
[2022/20]
Search report(s)International search report - published on:US21.01.2021
(Supplementary) European search report - dispatched on:EP19.06.2023
ClassificationIPC:G16H50/20, G16B25/10, G16B40/20, G01N33/574, G16H70/60
[2023/29]
CPC:
G01N33/57423 (EP,IL); G16H50/20 (EP,IL,US); G01N33/57484 (EP,IL);
G01N33/6863 (IL,US); G01N33/6869 (IL,US); G16B25/10 (EP);
G16B40/20 (EP); G16H10/40 (IL,US); G16H10/60 (IL,US);
G16H50/50 (IL,US); G16H50/70 (IL,US); G16H70/60 (EP,IL,US) (-)
Former IPC [2022/19]G16B25/00, G16B25/10, G16B40/20
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/19]
TitleGerman:VERBESSERUNG DER DIAGNOSE FÜR VERSCHIEDENE KRANKHEITEN UNTER VERWENDUNG VON AKTIVEN PROTEINEN EINER TUMORMIKROUMGEBUNG[2022/19]
English:IMPROVING DIAGNOSIS FOR VARIOUS DISEASES USING TUMOR MICROENVIRONMENT ACTIVE PROTEINS[2022/19]
French:AMÉLIORATION DU DIAGNOSTIC POUR DIVERSES MALADIES À L'AIDE DE PROTÉINES ACTIVES DU MICRO-ENVIRONNEMENT TUMORAL[2022/19]
Entry into regional phase28.01.2022National basic fee paid 
28.01.2022Search fee paid 
28.01.2022Designation fee(s) paid 
28.01.2022Examination fee paid 
Examination procedure28.01.2022Examination requested  [2022/20]
16.01.2024Amendment by applicant (claims and/or description)
16.01.2024Date on which the examining division has become responsible
Fees paidRenewal fee
15.06.2022Renewal fee patent year 03
14.06.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XI]WO2019032858  (OTRACES INC [US]) [X] 1,2,5-7,11-13 * whole document, in particular claims; paragraphs [0004], [0063], [0075], [0094]-[0098] and [0140]; Figures 8, 9 and 22 *[I] 8-10
International search[Y]US2008286776  (YOUNG ROBERT PETER [NZ]) [Y] 7 * claim 1; claim 2 *;
 [Y]US2012315641  (DUBINETT STEVEN M [US], et al) [Y] 4-15, 17-19, 21/5, 23 * para [0031]; claim 1; claim 3; claim 11; claim 12 *;
 [Y]US2013316374  (PENNINGER JOSEF [AT], et al) [Y] 12 * para [0013]; para [0019] *;
 [Y]WO2016115511  (UNIV LELAND STANFORD JUNIOR [US]) [Y] 9 * para [0003]; para [00127] *;
 [XDY]WO2017127822  (OTRACES INC [US]) [XD] 1-3, 16, 20, 21/1, 22, 24- 29 * para [0016]; para [0037]; para [0053]; para [0055]; para [0061]; para [0076]; para [0080]; para [0092]-[0093]; para [00125]; para [00153]; para [00163]; para [00227]; claim 1-2; claim 4; claim 10; claim15; claim 20; claim 29-32; claim 39; claim 41- 43 . * [Y] 4-15, 17-19, 21/5, 23;
 [Y]US2017281725  (SIMS TASHA NICHOLLE [US], et al) [Y] 13-14* Abstract; para [0033] *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.